Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -31.98x is 13% above its 1-year average of -36.74x, around the middle of its 1-year range (-88.82x–-7.18x).
34.84% below its 12-month average of -23.72x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2025 (2025-03-31): -7.18x.
INTEREST COVERAGE RATIO
-31.98x
INTEREST COVERAGE RATIO AVG TTM
-23.72x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-34.84%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 361 covered companies
CURRENT VS SECTOR MEDIAN
-654.25%
vs the sector median at left
Kalaris Therapeutics Inc
Market Cap
$65.26M
Interest Coverage Ratio
-31.98x
TTM Avg
-23.72x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$66.27M
Interest Coverage Ratio
-21.57x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.16M
Interest Coverage Ratio
-14.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.06M
Interest Coverage Ratio
-66.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.63M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$62.78M
Interest Coverage Ratio
0.34x
TTM Avg
0.34x
3Y Avg
1.90x
5Y Avg
3.13x
Market Cap
$67.94M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.27M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.33M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kalaris Therapeutics Inc (KLRS) | $65.26M | -31.98x | -23.72x | N/A | N/A |
| Cingulate Inc. (CING)vs › | $66.27M | -21.57x | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.16M | -14.86x | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.06M | -66.90x | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $67.63M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $62.78M | 0.34x | 0.34x | 1.90x | 3.13x |
| PDS Biotechnology Corporation (PDSB)vs › | $67.94M | -5.91x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | -8.06x | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $69.33M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $70.09M | -663.04x | N/A | N/A | N/A |
Interest Coverage
-32.0x
Debt/Equity
0.02
Current Ratio
10.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-03-31 | -7.18x |
| 2024-09-30 | -46.44x |
| 2024-06-30 | -8.39x |
| 2024-03-31 | -32.86x |
| 2023-12-31 | -88.82x |
